Proteinosis alveolar pulmonar en mujer embarazada tratada con lavado pulmonar total

Iván Baños Álvarez; Gabriel Ibarra Jimenez

Proteinosis alveolar pulmonar en mujer embarazada tratada con lavado pulmonar total

Pulmonary alveolar proteinosis in a pregnant woman treated with whole-lung lavage

Publicado 2009-06-01

Abrir | Descargar

PDF FLIP

Número

Vol. 21 Núm. 2 (2009)

Sección

Reporte de caso

Cómo citar

Proteinosis alveolar pulmonar en mujer embarazada tratada con lavado pulmonar total.

rev. colomb. neumol. [Internet]. 2009 Jun. 1 [cited 2024 Dec. 22];21(2):78-83.

DOI

Licencia

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Iván Baños Álvarez

Servicio de Neumología, Clínica Universitaria San Juan de Dios. Cartagena, Colombia.

Gabriel Ibarra Jimenez

Servicio de Neumología, Clínica Universitaria San Juan de Dios. Cartagena, Colombia.

Mostrar biografía de los autores

proteinosis alveolar pulmonar,

embarazo

lavado pulmonar total

Una mujer de 24 años se presentó con disnea progresiva hasta el reposo, tos con expectoración blanca escasa, durante el segundo trimestre de embarazo. Con antecedentes de pericarditis, sin historia previa de tabaquismo.
Durante su hospitalización fue desembarazada, previa maduración fetal; seguidamente fue sometida a biopsia pulmonar abierta, con diagnóstico de proteinosis alveolar pulmonar (PAP). Finalmente, se sometió a lavado pulmonar total secuencial, con notable mejoría de la disnea. Este caso es otro ejemplo de la seguridad y eficacia del lavado pulmonar total en el manejo de la proteinosis alveolar pulmonar

Visitas del artículo 36 | Visitas PDF 38

Descargas

Los datos de descarga todavía no están disponibles.

Rosen SH, Castleman B, Liebow AA. Pulmonary alveolar proteinosis. N Engl J Med 1958; 258: 1123-43.
Crocker HL, Pfitzner J, Doyle IR, et al. Pulmonary alveolar proteinosis: two contrasting cases. Eur Respir J 2000; 15: 426-9.
Matuschak GM, Owens GR, Rogers RM, et al. Progressive intrapartum respiratory insufficiency due to pulmonary alveolar proteinosis. Amelioration by therapeutic whole-lung bronchopulmonary lavage. Chest 1984; 86:496-9
Durán R. Alveolar fosfolipoproteinosis (10 cases in 12 years of experience). Rev Colom de Neumol 2004; 16: 8-13.
Ortega H, Ortega J, Ramirez R, Echeverri F, Restrepo C. Treatment to pulmonary alveolar Proteinosis with total bronchoalveolar lavage. Rev Colom de Neumol 2005; 17: 69-78.
Selecky PA, Wasserman K, Benfield JR, Lippmann M. The clinical and physiological effect of whole-lung lavage in pulmonary alveolar proteinosis: a ten-year experience. Ann Thorac Surg 1977; 24: 451-61.
Seymour JF, Dunn AR, Vincent JM, Presneill JJ, Pain MC. Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis. N Engl J Med 1996; 335: 1924-5.
Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, Gall JAM, et al. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoeisis but develop a characteristic pulmonary pathology. Proc Natl Acad Sci USA 1994;91:5592-6.
Dranoff G, Crawford AD, Sadelain M, Ream B, Rashid A, Bronson RT, et al. Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. Science 1994;264:713-6.
Burgess AW, Camakaris J, Metcalf D. Purification and properties of colony-stimulating factor from mouse lung-conditioned medium. J Biol Chem 1977; 252: 1998-2003.
Bradley TR, Metcalf D. The growth of mouse bone marrow cells in vitro. Aust J Exp Biol Med Sci 1966;44:287–299. 112. Lieschke GJ, Burgess AW. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). N Engl J Med 1992; 327: 28-35.
Seymour JF, Dunn AR, Vincent JM, Presneill JJ, Pain MC. Efficacy of granulocyte-macrophage colony-stimulating factor in acquired alveolar proteinosis. N Engl J Med 1996; 335:1924-5.
Tanaka N, Watanabe J, Kitamura T, Yamada Y, Kanegasaki S, Nakata K. Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor. FEBS Lett 1999; 442: 246-50.
Kitamura T, Tanaka N, Watanabe J, Uchida K, Kanegasaki S, Yamada Y, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocytemacrophage colony stimulating factor. J Exp Med 1999; 190: 875-80.
Kitamura T, Uchida K, Tanaka N, Tsuchiya T, Watanabe J, Yamada Y, et al. Serological diagnosis of idiopathic pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2000; 162: 658-62.
Goldstein LS, Kavuru MS, Curtis-McCarthy P, Christie HA, Farver C, Stoller JK. Pulmonary alveolar proteinosis: clinical features and outcome. Chest 1998; 114: 1357-62.
Shah PL, Hansell D, Lawson PR, Reid KB, Morgan C. Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis. Thorax 2000; 55: 67-77.
Mazzone P, Thomassen MJ, Kavuru M. Our new understanding of pulmonary alveolar proteinosis: what an internist needs to know. Cleve Clin J Med 2001; 68: 977-84.
Minakata Y, Kida Y, Nakanishi H, Nishimoto T, Yukawa S. Change in cytokeratin 19 fragment level according to the severity of pulmonary alveolar proteinosis. Intern Med 2001; 40: 1024-7.
Takahashi T, Munakata M, Suzuki I, Kawakami Y. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis. Am J Respir Crit Care Med 1998; 158: 1294-8.
Nakajima M, Manabe T, Niki Y, Matsushima T. Serum KL-6 level as a monitoring marker in a patient with pulmonary alveolar proteinosis. Thorax 1998; 53: 809-11.
Births, marriages, divorces, and deaths: provisional data for 1999. Natl Vital Stat Rep 2001; 48: 1-2.
Crocker HL, Pfitzner J, Doyle IR, Hague WM, Smith BJ, Ruffin RE. Pulmonary alveolar proteinosis: two contrasting cases. Eur Respir J 2000; 15: 426-9.
Wang BM, Stern EJ, Schmidt RA, Wasserman K. Evaluation of solutions used for lung lavage in alveolar proteinosis. Rounds of the Teaching Staff of Wadsworth Hospital Centre 1968;11: 217-22.
Maygarden SJ, Iacocca MV, Funkhouser WK, Novotny DB. Pulmonary alveolar proteinosis: a spectrum of cytologic, histochemical, and ultrastructural findings in bronchoalveolar lavage fluid. Diagn Cytopathol 2001; 24: 389-95.
Costello JF, Moriarty DC, Branthwaite MA, Turner-Warwick M, Corrin B. Diagnosis and management of alveolar proteinosis: the role of electron microscopy. Thorax 1975; 30: 121-32.
Gilmore LB, Talley FA, Hook GER. Classification and morphometric quantification of insoluble materials from the lungs of patients with alveolar proteinosis. Am J Pathol 1988; 133: 252-64.
Davidson JM, Macleod WM. Pulmonary alveolar proteinosis. Br J Dis Chest 1969; 63: 13-28.
Moertel CG, Woolner LB, Bernatz PE. Pulmonary alveolar proteinosis: report of case. Proc Mayo Clin 1959; 34: 152-7.
Ramirez RJ, Campbell GD. Pulmonary alveolar proteinosis: endobronchial treatment. Ann Intern Med 1965;63:429–441.
Ramirez J, Kieffer RF Jr, Ball WC Jr. Bronchopulmonary lavage in man. Ann Intern Med 1965; 63: 819-28.
Wasserman K. Evaluation of solutions used for lung lavage in alveolar proteinosis. Rounds of the Teaching Staff of Wadsworth Hospital Centre 1968;11:217-22.
Kao D, Wasserman K, Costley D, Benfield JR. Advances in the treatment of pulmonary alveolar proteinosis. Am Rev Respir Dis 1975; 111:361-3.
Sunderland WA, Klein RL. Heparin absorption during heparin-saline lavage in a patient with pulmonary alveolar proteinosis. Chest 1973; 63: 1033-4.
Hammon WE, McCaffree DR, Cucchiara AJ. A comparison of manual to mechanical chest percussion for clearance of alveolar material in patients with pulmonary alveolar proteinosis (phospholipidosis). Chest 1993; 103: 1409-12.
Seymour JF, Presneill JJ, Schoch OD, Downie GH, Moore PE, Doyle IR, et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med 2001; 163: 524-31.
Mazzone PJ, Sullivan EJ, Piccin R, Stoller JK, Thomassen MJ, Kavuru MS. Granulocyte macrophage-colony stimulating factor therapy for pulmonary alveolar proteinosis [abstract]. Am J Respir Crit Care Med 2000; 161: A888.
Barraclough RM, Gillies AJ. Pulmonary alveolar proteinosis: a complete response to GM-CSF therapy. Thorax 2001; 56: 664-5